|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,461,833 |
|
|
Indirect Value
|
$12,984,280,034 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,066,741,867 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$782 |
I/I |
295 |
5,103 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-07 |
4 |
B |
$5.72 |
$790 |
I/I |
138 |
105,243 |
1.42 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-07 |
4 |
S |
$13.00 |
$793 |
I/I |
(61) |
935,813 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-08 |
4 |
S |
$13.00 |
$793 |
I/I |
(61) |
935,752 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-21 |
4 |
B |
$5.90 |
$798 |
I/I |
132 |
191,729 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-09 |
4 |
B |
$6.96 |
$814 |
I/I |
117 |
190,700 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$816 |
I/I |
103 |
476,722 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-04-28 |
4 |
B |
$1.79 |
$845 |
I/I |
472 |
923 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$854 |
I/I |
322 |
5,735 |
1.42 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
B |
$7.30 |
$854 |
I/I |
117 |
43,002 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-05 |
4 |
S |
$8.11 |
$855 |
I/I |
(105) |
1,841 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-28 |
4 |
B |
$4.90 |
$858 |
I/I |
175 |
53,503 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
S |
$7.38 |
$863 |
I/I |
(117) |
42,885 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-04-12 |
4 |
B |
$3.57 |
$864 |
I/I |
242 |
242 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$873 |
I/I |
97 |
363,765 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-09 |
4 |
S |
$13.00 |
$884 |
I/I |
(68) |
28,734 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-01-31 |
4 |
B |
$3.02 |
$909 |
I/I |
301 |
301 |
1.42 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-11 |
4 |
B |
$10.94 |
$919 |
I/I |
84 |
281,949 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$919 |
I/I |
34 |
194,218 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$933 |
I/I |
352 |
6,253 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$933 |
I/I |
103 |
476,588 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$934 |
I/I |
34 |
194,252 |
2.17 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2010-09-28 |
4 |
B |
$2.45 |
$941 |
I/I |
384 |
384 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$971 |
I/I |
112 |
129,393 |
1.42 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.89 |
$978 |
I/I |
200 |
263,500 |
1.42 |
- |
|
1397 Records found
|
|
Page 10 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|